Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H F Dullens

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
European Journal of Cancer|November 1, 1974
Eradication of tumour cells by successive injections of allogeneic immune and hyperimmune peritoneal cells in a murine lymphoma systemH F Dullens, R A Woutersen, R A de Weger, et al.
Journal of Immunological Methods|January 1, 1981
Isolation of mast cells from murine peritoneal cell populations by velocity sedimentation at unit gravityH F Dullens, C Van Basten, R A De Weger, et al.
Cancer Research|December 15, 1989
Immunotherapy of mice with a large burden of disseminated lymphoma with low-dose interleukin 2R A Maas, H F Dullens, W H De Jong, et al.
International Journal of Tissue Reactions|January 1, 1982
Peritoneal cell populations during tumour injectionE De Heer, J W De Groot, W Den Otter, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Intratumoral low-dose interleukin-2 induces rejection of distant solid tumourR A Maas, D H Van Weering, H F Dullens, et al.
Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission|January 1, 1991
Acid ethanol fixation and polyester wax embedding combines preservation of antigenic determinants with good morphology and enables simultaneous bromodeoxyuridine (BrdU) labelingP J Roholl, H F Dullens, J Kleijne, et al.
Immunology Today|October 8, 2014
Mathematical analysis of the cellular immune reaction against tumour cellsR A De Weger, H F Dullens, R J De Boer, et al.
Pharmaceutical Research|December 1, 1993
Interleukin-2-containing liposomes: interaction of interleukin-2 with liposomal bilayers and preliminary studies on application in cancer vaccinesJ J Bergers, W Den Otter, H F Dullens, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
A survey of some formal models in tumor immunologyH F Dullens, M W Van der Tol, R A De Weger, et al.
In Vivo (Athens, Greece)|November 1, 1991
Tumour regression by IL-2 mediated stagnation of blood flowH J De Mik, J W Koten, R A Maas, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
European Journal of Cancer|November 1, 1974
Eradication of tumour cells by successive injections of allogeneic immune and hyperimmune peritoneal cells in a murine lymphoma systemH F Dullens, R A Woutersen, R A de Weger, et al.
Journal of Immunological Methods|January 1, 1981
Isolation of mast cells from murine peritoneal cell populations by velocity sedimentation at unit gravityH F Dullens, C Van Basten, R A De Weger, et al.
Cancer Research|December 15, 1989
Immunotherapy of mice with a large burden of disseminated lymphoma with low-dose interleukin 2R A Maas, H F Dullens, W H De Jong, et al.
International Journal of Tissue Reactions|January 1, 1982
Peritoneal cell populations during tumour injectionE De Heer, J W De Groot, W Den Otter, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Intratumoral low-dose interleukin-2 induces rejection of distant solid tumourR A Maas, D H Van Weering, H F Dullens, et al.
Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission|January 1, 1991
Acid ethanol fixation and polyester wax embedding combines preservation of antigenic determinants with good morphology and enables simultaneous bromodeoxyuridine (BrdU) labelingP J Roholl, H F Dullens, J Kleijne, et al.
Immunology Today|October 8, 2014
Mathematical analysis of the cellular immune reaction against tumour cellsR A De Weger, H F Dullens, R J De Boer, et al.
Pharmaceutical Research|December 1, 1993
Interleukin-2-containing liposomes: interaction of interleukin-2 with liposomal bilayers and preliminary studies on application in cancer vaccinesJ J Bergers, W Den Otter, H F Dullens, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
A survey of some formal models in tumor immunologyH F Dullens, M W Van der Tol, R A De Weger, et al.
In Vivo (Athens, Greece)|November 1, 1991
Tumour regression by IL-2 mediated stagnation of blood flowH J De Mik, J W Koten, R A Maas, et al.
Pageof 7